z-logo
Premium
Long‐term coeliac disease influences risk of death in patients with type 1 diabetes
Author(s) -
Mollazadegan K.,
Sanders D. S.,
Ludvigsson J.,
Ludvigsson J. F.
Publication year - 2013
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.12092
Subject(s) - medicine , hazard ratio , type 1 diabetes , coeliac disease , proportional hazards model , confidence interval , diabetes mellitus , risk factor , cause of death , disease , endocrinology
Aim The aim of this study was to examine mortality in patients with both type 1 diabetes ( T 1 D ) and coeliac disease ( CD ). Methods Between 1969 and 2008, we identified individuals with CD through biopsy reports from all pathology departments ( n  =   28) in S weden. T 1 D was defined as a diagnosis of diabetes recorded in the S wedish N ational P atient R egister between 1964 and 2009 in individuals aged ≤30 years. During follow‐up, we identified 960 patients with both T 1 D and CD . For each individual with T 1 D and CD , we selected up to five subjects with T 1 D alone (i.e. no CD ), matched for sex, age and calendar period of diagnosis, as the reference group ( n  =   4608). Using a stratified C ox regression analysis with CD as a time‐dependent covariate, we estimated the risk of death in patients with both T 1 D and CD compared with those with T 1 D alone. Results Stratifying for time since CD diagnosis, CD was not a risk factor for death in patients with T 1 D during the first 5 years after CD diagnosis [hazard ratio ( HR ) 0.87, 95% confidence interval ( CI ) 0.43–1.73], but thereafter the HR for mortality increased as a function of follow‐up time (5 to <10 years, HR 1.44, 95% CI 0.74–2.79; 10 to <15 years, HR 1.88, 95% CI 0.81–4.36). Having a CD diagnosis for ≥15 years was associated with a 2.80‐fold increased risk of death in individuals with T 1 D (95% CI 1.28–6.12). Conclusion A diagnosis of CD for ≥15 years increases the risk of death in patients with T 1 D .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom